##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 60 Download : 52

##plugins.themes.academic_pro.article.main##

Abstract

This article defins chlamydial pneumonia, this disease, a subtype of atypical pneumonia, poses a significant health concern, particularly among pediatric populations. This retrospective study aims to investigate the clinical characteristics and treatment outcomes of chlamydial pneumonia in children aged 3 to 8 years. A total of 26 children with confirmed Chlamydia pneumoniae infection were examined, revealing notable respiratory and extrapulmonary manifestations. Clinical presentation varied, with symptoms ranging from rhinitis and tracheobronchitis to unproductive cough, fever, and chest pain. Bronchoobstructive syndrome was prevalent, accompanied by leukocytosis, eosinophilia, and accelerated erythrocyte sedimentation rate (ESR). Radiographic findings predominantly showed interstitial changes and increased vascular components. Macrolides emerged as the primary therapeutic agents, leading to clinical recovery within 10-14 days. These findings underscore the importance of early recognition and appropriate management of chlamydial pneumonia in pediatric patients.

Keywords

Chlamydial pneumonia pediatric patients clinical features treatment outcomes

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Satibaldieva Nasiba Rajabovna, & Babajanova Charos. (2024). Clinical and morphological features of chlamydial pneumonia. Texas Journal of Medical Science, 32, 24–26. https://doi.org/10.62480/tjms.2024.vol32.pp24-26
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Grayston J.T., Kuo C.C., Wang S.P. et al. A new Chlamydia psittaci strain called TWAR from acute respiratory tract infections. N. Engl. J. Med. 1986; 315 (3): 161–168.
  2. Lynch J.P. III, Toews G.B. Community acquired pneumonia. In: Khan M.G., ed. Cardiac and pulmonary management. London: Lea&Febiger; 1993. 618–635.
  3. Синопальников А.И. Внебольничные инфекции нижних дыхательных путей. В кн.: Чучалин А.Г., Синопальников А.И., Страчунский Л.С. Пневмония. М.: ООО "Ме дицинское информационное агенство"; 2006. 17–49.
  4. Екимов А.Н. Детекция возбудителей атипичной пнев монии. В кн.: Чучалин А.Г., Синопальников А.И., Страчунский Л.С. Пневмония. М.: ООО "Медицинс кое информационное агенство"; 2006. 84–88.
  5. Chorieva, Z. Y., Dzhuraev, I. B., Fayzieva, U. R., Satibaldiyeva, N. R., & Ashurova, A. S. (2021). Influence of Environmental Indicators on the Development of Broncho-pulmonary Pathology in Children. European Journal of Molecular & Clinical Medicine, 7(11), 4419-4425.
  6. Sultanov, A. T., Fayzieva, U. R., Satibaldieva, N. R., & Chorieva, Z. Y. (2019). CLINICAL AND ANAMIC CHARACTERISTICS OF COMMUNICATIVE PNEUMONIA IN CHILDREN. Central Asian Journal of Pediatrics, 2(1), 85-89.
  7. Тартаковский И.С. Современные подходы к диагностике атипичных пневмоний. Клин. микробиол. и анти микроб. химиотер. 2000; 2: 60–68.
  8. Murdoch D.R. Nucleic acid amplification tests for the diagnosis of pneumonia. Clin. Infect. Dis. 2003; 36: 1162–1170. 7. Данциг И.И., Скипский И.М., Смульская Г.П. Затяжная пневмония: факторы риска и лечебная тактика. Тер. арх. 1999; 71 (3): 32–35